Target Name: MIR6731
NCBI ID: G102465437
Review Report on MIR6731 Target / Biomarker Content of Review Report on MIR6731 Target / Biomarker
MIR6731
Other Name(s): hsa-miR-6731-3p | hsa-mir-6731 | microRNA 6731 | MicroRNA 6731 | hsa-miR-6731-5p

MIR6731: A Potential Drug Target and Biomarker

MIR6731 (hsa-miR-6731-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study and develop new treatments.

MIR6731 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in gene expression regulation. It is expressed in a variety of tissues and cells and is involved in the regulation of various biological processes, including cell growth, apoptosis, and inflammation.

One of the key features of MIR6731 is its expression pattern. It is highly expressed in various tissues, including the brain, heart, and liver, and is also expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This makes it an attractive target for cancer therapies that aim to reduce the expression of MIR6731.

Another important factor to consider is MIR6731's sequence. Its unique sequence consists of 20 amino acid residues, which are primarily composed of glycans and uridine nucleotides. This sequence gives MIR6731 a unique structure that is distinct from other miRNAs.

MIR6731 has also been shown to play a role in the regulation of cellular processes that are important for human health. For example, it has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs.

In addition to its potential role in cancer, MIR6731 has also been shown to be involved in a variety of other biological processes that are important for human health. For example, it has been shown to play a role in the regulation of inflammation, which is important for maintaining immune function and preventing disease.

Given its unique structure and expression pattern, MIR6731 is an attractive target for researchers to study and develop new treatments. Researchers are currently working to identify small molecules that can specifically target MIR6731 and inhibit its expression. These small molecules are being tested for their potential as either anti-cancer agents or biomarkers for various diseases.

In addition to its potential as a drug target, MIR6731 is also a potential biomarker for several diseases. Its unique expression pattern and sequence make it an attractive target for diagnostic tests, such as qRT-PCR, RNA-seq, and western blotting. These tests can be used to measure the expression and distribution of MIR6731 in various tissues and cells, which can provide valuable information for the diagnosis and treatment of diseases.

In conclusion, MIR6731 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments. As research continues, it is likely that the role of MIR6731 in various biological processes will become increasingly clear, and its potential as a drug target and biomarker will continue to be explored.

Protein Name: MicroRNA 6731

The "MIR6731 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6731 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826